Target intelligence / Profile preview

DnaJ heat shock protein family member B2 (DNAJB2)

Target
DNAJB2
Molecular classification
Molecular chaperone, Co-chaperone (Hsp40 family), Ubiquitin-interacting protein, Protein quality control protein
01

Overview

DnaJ heat shock protein family member B2 (DNAJB2) is a molecular chaperone protein in the Hsp40 family, primarily expressed in neurons. DNAJB2 acts as a co-chaperone that binds unfolded and misfolded proteins, facilitating their correct folding and promoting their ubiquitin-dependent degradation via the proteasome, mostly through regulation and activation of Hsp70 chaperones[1][2]. It plays an essential role in neuronal proteostasis, protecting cells from toxic protein aggregation. Two major isoforms—DNAJB2a (cytosolic/nuclear) and DNAJB2b (membrane-associated)—have distinct cellular localizations but share core functions[1]. Disease-linked mutations in *DNAJB2* lead to inherited neurodegenerative diseases, such as Charcot-Marie-Tooth disease type 2T and distal hereditary motor neuropathies, through loss of chaperone-mediated protein quality control[1]. DNAJB2 is being investigated as a potential therapeutic target for reducing toxic protein inclusions in neurodegenerative conditions, although no drugs currently target this chaperone directly[1][2].

Other names
DnaJ homolog subfamily B member 2HSJ1HSPF3HSJ-1CMT2THeat shock 40 kDa protein 3Heat shock protein J1DSMA5HMNR5neuronal DNAJ-like 1dnaJ protein homolog 1
02

Mechanism of action

Enhancement of proteasomal degradation of misfolded proteins; Modulation of Hsp70 chaperone function; Inhibition of toxic protein aggregation; Protein homeostasis restoration

03

Biological functions

Protein foldingProtein homeostasis (proteostasis)Prevention of protein aggregationPromotion of degradation of misfolded proteins via the proteasomeRegulation of Hsp70 ATPase activityNeuronal protection from proteotoxic stress
04

Disease associations

Neurodegenerative diseaseCharcot-Marie-Tooth disease (type 2T)Distal hereditary motor neuropathy (dHMN or DSMA5)Spinal muscular atrophy (rare forms)Atypical juvenile parkinsonism (rare forms)
05

Safety considerations

Loss-of-function mutations can cause inherited neuropathiesDeficiency may increase risk for neurodegenerationOveractivity or abnormal chaperone modulation theoretically could influence protein turnover dysregulation, but specific drug safety concerns are not established in the literature

Beyond the preview

Go deeper on DnaJ heat shock protein family member B2 (DNAJB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DnaJ heat shock protein family member B2 (DNAJB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call